Frontiers Media SA provides LaTeX templates for many of its journals. Check this journal’s author guidelines, and we can convert your manuscript into its template.
LaTeX Template Conversion →Journals listed in Web of Science and JCR receive many submissions and desk reject a large share. A section-by-section audit by a PhD reviewer in your area shows what to fix first.
Manuscript Auditing →01Impact factor
Impact factor of Frontiers in Oncology (2026)
The impact factor shown here is the 2-year mean citedness: citations received in a year by the papers Frontiers in Oncology published in the two previous years, divided by the number of those papers. That is the same formula as the Journal Impact Factor, applied to the open citation data of OpenAlex. The journal is listed in JCR 2024, so it also has an official Journal Impact Factor published by Clarivate, which can differ because it counts citations from Web of Science journals only.
Rank in its subject categories
- Q2Oncologyrank 142 of 347 journals
Quartiles here rank journals of the same Web of Science category by 2-year citedness; they are not the official JCR quartiles.
Citations and papers per year
Open access (listed in DOAJ); article processing charge listed at about US$3,801.
02Fee waivers
APC waivers and discounts for Frontiers in Oncology
Frontiers in Oncology follows the waiver policy of its publisher, Frontiers: no country list; fee support is granted case by case on demonstrated need. No country rule: the publisher decides case by case, or has no waiver scheme.
Waivers apply to fully open access journals. If Frontiers in Oncology is a hybrid journal, you can publish without any fee through the subscription route.
Checking the waiver rules for your country…
Retractions and research integrity at Frontiers in Oncology
Retractions per year
Most common reasons (a retraction can have several):
Frontiers in Oncology has 84 retracted papers in the Retraction Watch database, the latest in May 2026. A retraction count is not a verdict on a journal: large journals publish more and journals that investigate actively retract more. The trend and the reasons tell you more than the number. Retractions for paper mills or compromised peer review usually come in batches after an investigation; check whether they are recent before you decide.
Submitting to Frontiers in Oncology? See your rejection risk first.
Seven questions our reviewers ask in every audit, plus your abstract and the fit with this journal. Free, no sign-up, about 2 minutes.
03Indexing
Indexing of Frontiers in Oncology
- ISSN
- 2234-943X
- Publisher
- Frontiers Media SA
- Country
- Switzerland
- Language
- English
- Scopus source type
- Journal
- Web of Science categories
- Oncology
From the indexing lists used on ScholarsColab, updated 1 March 2026. Indexing can change: confirm on the Web of Science Master Journal List or the Scopus source list before submitting. Official Journal Impact Factors and JCR quartiles are published by Clarivate; the impact factor and quartile on this page are calculated from OpenAlex open data (see how the impact factor works).
04What it publishes
What Frontiers in Oncology publishes: real papers
Words that appear most often in the titles of the papers published here that we track. Choose one to see those papers:
05Published papers
Papers published in Frontiers in Oncology
Papers from the publication records ScholarsColab tracks, with their year and citations. Author names are not shown.
- Zhao Guangsheng1, Liu Song2, 3, Yin Shunhang1, Ding Zhongyi1, Tang Shunxiong1, Zhou Jun1 and Zhang Yuewei420260 citations
- Prognostic value of nutritional and inflammation-based scores in advanced soft tissue sarcoma treated with trabectedin: a multicenter study20260 citations
- Zhilin Gong1, 2, Hansen Lin1, Jue Wang3, Jintao Hua1, 2, Jinhuan Wei1, Wei Chen1, Junhang Luo1, Jun Pang2 and Xu Chen120260 citations
- Robust prostate cancer risk stratification from unregistered mpMRI via learned cross-modal correspondence20260 citations
- Primary pulmonary NUT carcinoma with NSD3–NUTM1 fusion treated with dose-escalated adaptive radiotherapy and multimodal therapy: case report20260 citations
- Menglu Li1, 2, 3, 4, Xinwei Liu1, 2, Yuhui Xue1, 2, Yichen Lu3, Zhiqiang Chen1, 2, Yuwei Zhang4, Weiguo Chen5, Shan-Chao Zhao6, Ke Wang7 and Ninghan …20260 citations
- Research on a method for early diagnosis and progression prediction of cervical cancer based on imaging omics and molecular omics20260 citations
- Machine learning–based multicenter prediction of postoperative sepsis in emergency colon cancer: role of surgical approach and inflammatory markers20260 citations
- Association of regional specificity of blood-brain barrier permeability with pathological subtypes in cerebral white matter of patients with non-brain metastatic lung …20260 citations
- Development and validation of a multifactorial risk prediction model for breast cancer patients with co-occurring thyroid cancer: a retrospective matched case …20260 citations
- Breast cancer pathogenesis, diagnosis and treatment: a comprehensive review20260 citations
- Practical application of SAM for breast nodules segmentation20260 citations
- CT-based intratumoral habitat and peritumoral radiomics model to predict spread through air spaces in solid lung adenocarcinoma with diameter≤ 2 cm: a dual …20260 citations
- Assessing the robustness and clinical evaluation of a deep− learning segmentation model for head and neck cancer20260 citations
- Haimei Lan1, Chaosheng Wei1, Yiming Luo2, Mingzhuang Liao1, Hongfeng Liang1, Jianli Qin1, Jixing Yi1, Fengming Xu1, Dandan Huang1, Meiqing Zhang1 …20260 citations
- Robotic versus traditional laparoendoscopic single-site radical hysterectomy with no-manipulation technique: a retrospective cohort study20260 citations
- Targeted therapies in lung cancer: personalizing treatment across the age spectrum20260 citations
- Lihu Gu1, Qiufeng Zhang2, Yuying Hu3, Zhiyi Xiang2, Shengqiang Ji4, Weiming Yu5, Xingchen Liu6, Ping Chen1, Feng Wu1 and Qi Zheng120260 citations
- Federated learning for privacy-preserving skin cancer classification using deep neural networks20260 citations
- Gang Peng1, Peiyun Zhu2, Buhan Zhang3, 4, Zening Zhang5, Youjun Mao1, Risheng Yu6 and Jihong Sun420260 citations
- Yuanzi Liang1, Junqi Hu2, Tianhui Wu3, Dong Bai1 and Zhiqun Wang120260 citations
- Yujuan Gao1, Haoyu Xu2, Juan Li3, Minli Li2 and Desheng Zhu420260 citations
- Empowering photodynamic therapy with artificial intelligence: current trends and future directions20260 citations
- Jian-Peng Wang1, 2, Chen-Chen An2, 3, Zi-Ning Wang2, Zhi-Jian Wei4, 5 and Ying Dai1, 220260 citations
- miR-99b-5p inhibition drives apoptosis and tumor shrinkage in triple-negative breast cancer: functional characterization through AGO2-RIP-seq and mechanistic insights20260 citations
- Li Zhong1, Wei Chen1, Da Zheng1, Yuening Cao1, Ling Zhu1, Zefeng Zhu1, Luqin Liao1, Lilin Dai1, Xiaotao Wang2 and Zheng Zeng120260 citations
- XiaFeng Shen1, 2, LuYao Yang1, 2, ShiWei Wang1, 2 and JianLiang Shen1, 220260 citations
- Predicting lung metastasis after radical colorectal cancer surgery: a two center retrospective cohort study and nomogram development20260 citations
- Marie-Nicole Theodoraki1, 2, Linda Hofmann1, Helen Bauer1, Jonas Fleckner3, Reinhard Depping4, Christian Idel3, Kirstin Plötze-Martin3, Zuzana Penxova3 …20260 citations
- Studies on the functionality of the TC-NER ERCC6-M1097V protein variant frequently found in Louisiana patients with PCa upon UV damage20260 citations
- Xingxing Yuan1, Longfei Xu1, Changfei Gong1, Junming Jian1, Wenheng Zheng1, Changwei Luo1 and Yun Zhang1, 2, 320260 citations
- Jing Zhou1, 2, 3, Ben Li1, Tao Sun1, DaXue Li1, Chun Huang1, Han Gao1, Jiahui Ren1, Yuchen Zhuang1, Song Xue4, Qian Xiao1, 2, Lin Chun5 and Xinliang …20260 citations
- Integrating reproductive and metabolic factors for uterine fibroid risk assessment: a two-center machine learning study with SHAP interpretability20260 citations
- Regular nutritional monitoring in pediatric cancer patients undergoing radiotherapy: a prospective observational pilot study20260 citations
- Huan Jin1, 2, Cai Huang1, Ying Dong3, Qi Xiong3, Di Wang1, 2, Ziyi He1, 2, Yu Shang1, Lin Shen1, Chen Ma1, Zixian Wang1, Siwei Shi1, LingFeng Zeng4 …20260 citations
- Advancing cancer imaging technologies: bridging the gap from research to clinical practice20260 citations
- Feifan Song1, 2, Shiqiang Su1, Xueqiao Zhang1, 2, Yunpeng Cao1, 2, Xiongjie Cui1, 2, Lili Zhang1, Chao Li1, Shen Li1, Shuo Tian1 and Lizhe Liu320260 citations
- Furmonertinib plus pemetrexed in the treatment of EGFR exon 19 deletion lung adenocarcinoma: two20260 citations
- Yang Sun1, Yanan Chen1, Ting Liu2, Pan Pan1, Yongjuan Gu1, Xuexue Liang1, Dong Shen1 and Lixian Xu120260 citations
- Guo-Yu Ou1, Yin-Chuan Zhu1, Kun Li1, Cheng-Jie Li1, Xin Yi1, Qiu-Bin Wan1 and Hai-Lan Shen220260 citations
- Yanjun Zhang1, Xiaochen Han1, Zifeng Chi1, Ziqi Zhao2, Feifei Wang3, Dan Liu1 and Ruoling Han220260 citations
- Generation of deep learning based virtual contrast-enhanced CT images from noncontrast CT images for target volume delineation in cervical cancer radiotherapy20260 citations
- Sizhe Yang1, Yang Dai2, Qiyuan Li1, Sha Zhao1, Xueqin Deng1, Feifan Chen3, Yaping Zhang1, Yufang Wang3 and Wenyan Zhang120260 citations
- Zhendong Yang1, Huimin Xiao2, Xigui Li3, Zhuxin Wei1, Min Kang1, Rensheng Wang1 and Jianyuan Huang320250 citations
- Baolin Song, Huan Shao, Yanmei He, Xinwei Zhu and Pengfei Qin20250 citations
- Zheng Zhang1, 2, Xiao-hui Zhang3, Rong Huang1, 2, Jia-jia Fan1, 2, Xue-jiao Ma1, 2, Zi-han Jin2, Qin Wang1, 2, Yu-long Li1, 2 and Fei Su220250 citations
- Zhenyu Ke1, Hongbo Yang1, Meng Xing1, Shasha Bi2 and Fujun Yang120250 citations
- Kaihua Zhang1, 2, Wei Su1, 2, Jiayu Lin1, 2, Yingli Gao1, 2, Chunming Gu3, Ye Li4, Ning Jiang5, Yingtao Hao5, Hai Zhong6 and Weiquan Zhang520250 citations
- Zhihua Li1, Yiying Wang2, Da Xi3, Jian Wang1, Haiyang Lan1, Xiaoning He3, Na Zhao3, Juan Xiao3, Naiwen Mu3, Jianlong Li3, Lincheng Liu3 and Guanghui …20250 citations
- Zhiwen Zeng1, Kena Lin1, Xueqi Li2, 3, Tong Li2, Xiaoman Li1, Jiayi Li1, Zule Ning1, Qinxian Liu1, Shanghang Xie2, Sumei Cao2, 4 and Jinlin Du120250 citations
- Zhongquan Yi1, Xia Li2, Yangyang Li3, Rui Wang3, Weisong Zhang3, Hao Wang3, Yanan Ji1, Jing Zhao1 and JianXiang Song320250 citations
- Maryamosadat Mavaei1, 2, Simin Farokhi3, Mohammad Hasan Yousefi4, 5, 6, Arshia Fakouri3, Alireza Shadab7, 8, Mohammad Hossein Abdolmohammadi6 …20250 citations
- Mengling Hu1, Luyao Wang1, Feiyue Zhang1, Yiluo Xie2, Tingting Zhang1, Hongli Liu3, Zhenghong Li1 and Jing Zhang120250 citations
- Wenjun Zhou1, 2, Zhangcheng Liu1, 3, Jindong Zhang1, Shuai Su1, Yu Luo1, Lincen Jiang1, Kun Han1, Guohua Huang2, Jue Wang4, Jianhua Lan2 and Delin …20250 citations
- Extensive thoracic vertebral an d chest wall metastases as th e initial presentation of breas t cancer: a case report an d literature revie w20250 citations
- Results: Eleven of 50 models (22%) treated with veliparib plus temozolomide responded according to one or both metrics, as did 2/47 models (4.2%) treated …20250 citations
- Lin Tuo1, Li Ting Yan1, Ying Liu1, Shu Qiang Wang120250 citations
- Transformation of T-lymphoblastic lymphoma into acute myeloid leukemia after recurrence: a case report and20250 citations
- Min Ding1, 2, Tianrui He3, Jing Yu1, 2, Jian Zheng4, Song Wei5, Yuan Yuan1, Chunhui Yang6, Ning Luo7, Xin Qi8, Liting Liu1, 2, Yiyang Sun1, 2, Dailun Hou9 …20250 citations
- Ferroptosis's Master Switch GPX4 emerges as universal biomarker for precision immunotherapy: a pan-cancer study with in vitro20250 citations
- Simeng Lei, Yangkai Fu, Bo Zhang, Hanwen Yang, Yang Hu and Zhili Ji20250 citations
- Asako Yanagisawa, Takumi Fukaya, Kento Noda, Hiroshi Kojima and Hidefumi Shimizu20250 citations
- Yi-Fan Hui1, 2, Shao-Chen Song1, 2, Wen-Jian Zhu1, Shu Bu1, 2, Jin Sun3, Ting-Sheng Ling2 and Hai-Bo Cheng1, 2, 320250 citations
- Matteo Zoli1, 2, Giacomo Sollini3, Alessia Giorli3, Alessandro Carretta1, 2, Marcello Magnani2, Arianna Rustici4, Martina Conti3, Laura Maria Beatrice Belotti5 …20250 citations
- Yingxue Li1, Li Wang2, Lin Han1, Zheng Zheng1 and Jinqiang Yan120250 citations
- Yingyi Xia1, Zhiyu Ling2 and Hao Chen120250 citations
- Paolo Scollo, Kore University of Enna, Italy20250 citations
- Tangyi Wang1, Yadian Lei1, Jingwei Sun2, Li Wang1, Yuxin Lin1, Zhijing Wu1, Shoude Zhang3, Chengzhu Cao1, 4, 5 and Haiyan Wang1, 4, 520250 citations
- Faying Liu, Yang Zou, Qing Chen, Tao Chen, He Xiao, Tingbing Xie, Lihe Zheng, Qi Ruan and Wang Liu20250 citations
- Minghan Jiang1, 2, Zeyang Miao1, Run Xu1, Mengyao Guo1, Xuefeng Li1, Guanwu Li1, Peng Luo1 and Su Hu2, 320250 citations
- Advancements in artificial intelligence for ultrasound diagnosis of ovarian cancer: a comprehensive review.20250 citations
- Pu Zhou1, 2, Hongyan Qian1, Pengfei Zhu2, Jiangyuan Ben1, 2, Guifang Chen2, Qiuyi Chen2, Lingli Chen3, Jia Chen4 and Ying He1, 220250 citations
- Zixi Wang1, Xiaoyu Li2, Lili Jiang3, Weiya Wang3, Kai Xiao4, Ting Zhang5, Li Li6, Dan Li7 and Yongsheng Wang120250 citations
- Tao Luo, Hao Yang, Xingqiang Ran, Binwen Xu, Yue Zhang, Liwen Zhang, Chengcheng Zhang and Maoyong Fu20250 citations
- Mulan Pan1, Lu Lu2, Xingyu Mu1, 3 and Guanqiao Jin120250 citations
- Barriers to cancer screening uptake and approaches to overcome them: a systematic20250 citations
- Nan Jiang1, Xiaoxia Ping1, Qian Meng1, Yuanqing Liu1, Xi Wang2 and Chunhong Hu120250 citations
- Rong Su1, Yong Du2, Pan Tian3, Weifang Ma1, Yongfeng Hui4 and Shaoqi Yang120250 citations
- Haitao Wang, Changhua Ji, Chengjun Zhou and Hui Li20250 citations
- Pascal Caillet1, Frederic Balusson2, Nathalie Ganne-Carie 3, Emmanuel Oger2, Charlotte Costentin4 and Olivier Ganry520250 citations
- Chuansheng Yang1, Deping Luo2, Jian Xie1, Yingting Zou1, Fei Chen1, Wenchun Yang1, Linfeng Zeng1 and Jing Liu320250 citations
- Cheng Chen1, Yanfeng Shen1, Yanhong Ma2, Yingying Zhang1, Shuyan Zhang1, Na Su1, Hefei Guo1, Yapeng Guo1, Xuehui Zhang1, Xianming Liu1, Suhua …20250 citations
- Ali Ata Moazzami, Swedish University of Agricultural Sciences, Sweden20250 citations
- Shuai Cui1, Qifan Liu1, Hailong Wang1, Husha Li1, Wei Li1, Chenlong Li2, Leilei Bi3, Yang Mu4, Wenjing Guo1, Jundong Yao1 and Zhoulong Zhang120250 citations
- Shuanglong Xiong1, Chengxiang Yang1, Kaiwen Fu1, Xingyun Liao1, Yao Ding1, Kexue Zhou1, Li Zhang1, Yan Teng1, Chunman Wu2, Yongsheng Li1 …20250 citations
- Evaluation of the efficacy of 18 F20250 citations
- Chao Lu, Donggang Pan, Xiuhong Shan, Rao Dai, Bowen Liu, Zhixuan Wang and Xiaoxiao Wang20250 citations
- Shurong Niu, Lili Zhang, Lina Wang, Xue Zhang and Erniao Liu20250 citations
- Oral contrast-enhanced ultrasonographic features an d radiomics analysis to predict NIH risk stratification fo r gastrointestinal stromal tumor s20250 citations
- Ignazio Stanganelli1, 2, Serena Magi2, Elisabetta Costa3, Matelda Medri1, Franca Gentilini4, Chiara Scutellà4, Daniela De Zerbi5, Giorgia Ravaglia2, Silvia …20250 citations
- Qian Feng1, Xiaoxia Yan2, Liping Gao2, Hui Li2, Baik Sarah3, Russo Anna4 and Hongying Jiang120250 citations
- Qian Gao1, 2, Zhaonong Yao1, 2, Yuhong Yao1, 2, Yunxia Liu3, Jianshui Mao4 and Binghao Li220250 citations
- Qi-Jing Zhang1, 2, Jia-xin Zhou1, 3, Da-hai Hu4, Jing-hua Pan1, 5, Si-min Luo5, 6 and Qi Yao720250 citations
- Qing-Lin Ren1, Liu Lin2, Kai Chu3, Xin-Rong Xu4, Hui-Jun Wang1, Jun Wu4, Jin-Zhi You5, Jun-Xi Hu4, Xiao-Lin Wang4 and Yu-Sheng Shu420250 citations
- Qing Sheng Du1 and Bo Fan220250 citations
- Qiumiao Xu1, 2, Zhijiang Dai1, 2, Chengjin Peng1, 2, Qinghong Yan1, 2, Xiaoting Chen1, 2, Tongwei Liu1, 2, Ran Zhang1, Guoxin Huang1, Xinyao Liu1 and …20250 citations
- Tongbin Gao1, Yuan Gao1, Dawei Wang1, Yongchun Yu1, Zhentao Zhang2 and Feihu Tang220250 citations
- Gaolei Ma1, Lijie Ma2, Yuan Zhang3, Yuanyuan Chen1, Yingnan Zhang1, Wenwen Guo1, Zhiyuan Yao4 and Guijuan Ji220250 citations
- Wu Tenghui1, Liu Xinyi2, Si Ziyi2, Zhang Yanting2, Ma Ziqian3, Zhu Yiwen2 and Gan Ling220250 citations
- Ke-xun Li1, 2, Si-miao Lu1, 3, Chang-ding Li1, 4, Cheng-hao Wang1, Jia-hua Lv5, 6, Qi-feng Wang5, 6, Yun-chao Huang2, Yong-tao Han1, Xue-feng Leng1 …20250 citations
- Libin Li, Yizhi Liang and Wenji Xu20250 citations
- Chaoyang Zhang and Wei Hao20250 citations
- Mapping three decades of air pollution–lung cancer20250 citations
- Yu-cheng He1, 2, Xin-ye Dai1, 2, Ying-hao Lv1, 2, Xiao-juan Yang2, 3, Qing-yun Xie1, 2, Si-nan Xie1, 2, Yun-shi Cai1, 2, Feng-wei Gao1, 2 and Tian Lan1, 220250 citations
- Yue Hou1, 2, Tianming Zhang1, Kaibo Zhu2, 3, Jing Jiang1, 2 and Hong Wang120250 citations
- Yufei Zhou1, Qiangqiang Zheng2, Yunfeng Zhou2, Xiong Liu2, Wei Chen2, Yusong Lu2 and Yang Yuan220250 citations
- Bailin Wang1, Long Liu2, Meiqi Cui3, Qianwen Ye4, Panhua Li4 and Bing Yan420250 citations
- Yulai Yin1 and Xiaoyu Zhang220250 citations
- Yunyan Zheng1, Hui Zhang2, Huijian Chen1, Yang Song3, Ping Lu4, Mingping Ma1, Mengbo Lin2 and Muzhen He120250 citations
- Jiafu Xiao1, 2, 3, Wuhao Liu1, 2, 3, Jianxin Gong1, 2, 3, Weifeng Lai1, 2, 3, Neng Luo1, 2, 3, Yingfan He1, Junrong Zou2, 3 and Zhihua He2, 3, 420250 citations
- Network pharmacology integrated with molecular docking and experimental validation elucidates the therapeutic potential of20250 citations
- Yun Zhu1, Shuni Zhang1, Wei Wei2, Li Yang1, Lingling Wang3, Ying Wang1, Ye Fan4, Haitao Sun5 and Zongyu Xie120250 citations
- Yuqin Long1, Rong Zhao2 and Xianfeng Du320250 citations
- Jiamiao Hu, Yue Jin, Mengjia Wang, Yuke Pang, Shenkangle Wang, Xuyun Xie, Zhewen Wang and Xiaonan Sun20250 citations
- Hong Fu1, 2, Yanhua Huang3, Baochun Lu1, 2, Jianhua Yu1, 2, Difan Zhou1, 2, Chuanling Hou4, Luohang Xu5 and Hongwei Qian1, 220250 citations
- Liyang Su, Qiaojie Xie, Aling Yi, Qingquan Zhang and Jinzhen Chen20250 citations
- Yuting Huang1, Jie Yang2, Peisen Liu3, Jinnan Xuan4, Xin Xiao1, Chao Wang1, Fanliang Meng2, Hao Mou1, Xu Zhang5 and Shuang Ji320250 citations
- Jianxin Xue, Sichuan University, China20250 citations
- Yuting Liao1, Wenliang Zhu2 and Jianquan Zhang120250 citations
- Jia Shi1, 2, Danni Qiao3, Qiongyang Lv3, Yaliang Fan3, Haibin Yu2, Guiming Hu1, Longhao Wang3 and Beibei Sha120250 citations
- Jiaxin Hao1, 2, Yijia Gong1, 2, Xiaowen Zhang1, 3, 4, Minghong Du1, 3, 4, Huan Wang1, 3, 4, Guolin Guo4, Mengqing Zhou4, Tian Tian4 and Hongguo Rong1 …20250 citations
- Hongxi Chen1, Zidan Lin2, Jing Chen2 and Shanyang He120250 citations
- Jiaxin Ren1, 2, Ling Gu2 and Xue Tang2, 320250 citations
- Yuxiang Sun1, 2, Junpeng Xu2, Dongsheng Kong2, Yu Zhang3, Qijia Wu2, Liqin Wei2, Zihao Zhu1, Chunhui Li1 and Shiyu Feng220250 citations
- Jiayao Xu1, Jiabei Gong2, Huiqiong Han1, Zehua Wang1, Wenjia Wang1, Lei Wang1, Xin Sui1, Guanyu Chen3, Yongxu Jia1 and Yanru Qin120250 citations
- Xiangyu Li, Min Zhuang, Ziyue Hu, Xiaoxiao Xie, Likun Cui and Man Lu20250 citations
- Yu Yang1, 2, Yiwei Hou1, 3, Li Yi4, Chongyuan Chen1, 2, Xiang Li4, Yashan Wang4, Yunxi Fu4, Mingzheng Hu1, 2 and Rongchun Xing1, 220250 citations
- Yu Yang1, 2, Yiwei Hou1, 3, Li Yi4, Mingzhi Jiang5, Lihua Tang1, 6, Mingzheng Hu1, 2 and Rongchun Xing1, 220250 citations
- Xiaochen Chen1, 2, Huiping Yan1, Hongyang Zhao1 and Pengfei Zhu120250 citations
- Jihan Wang1, Shengxian Bao2, Tongtong Huang1, Yongzhi Cai1, Binbin Jin1 and Ji Wu120250 citations
- Xiaoxiao Li1, 2, Junfang Fang2, Fuqian Wang2, Lin Zhang2, Xingyue Jiang2 and Xijin Mao220250 citations
- Jing Cheng1, 2, Zhihan Liu3, Haibo Liu1, 2, Chao Fang4 and Jun Li320250 citations
- Jingjing Gao1, 2, Jingshu Xu3, Yiyue He3, Dan Zong1, 2, Tong Jin1, 2 and Xia He1, 220250 citations
- Xijia Zhang1, Xinfa Wang2, Weihai Ning3, Jianfeng Liang4, Yonglong Jin5, Yuqian Nie6, Jie Wang7, Zishen Wang7, Wei Wang8, Jun Zhao6, Jingjing Kong6 …20250 citations
- Jing Xu1, Pan Qi2, Xiaoyan Ou2, Qiaoxin Zhong3, Zhen-Wen Chen2, Yin Wang2, Aijiao Yi2 and Bin Wang220250 citations
- Jingyi Ren1, Jinbo Lu2, Xun Shi1 and Yuexin Cheng220250 citations
- Noemie N. Moreau1, 2, Samuel Valable2, Cyril Jaudet1, Loïse Dessoude3, Leleu Thomas3, Romain Herault4, Romain Modzelewski5, 6, Dinu Stefan3, Juliette …20250 citations
- Jing Zhang1, Qiyuan Li1, Haoyu Liang2, Yao Wang1, Li Sun1, Qingyuan Zhang1 and Chuanping Gao120250 citations
- Beibei Ji, Wei Luan, Rula Sha and Wenxin Li20250 citations
- Xinyi Guo1, 2, Yue Ling1, 2, Yulan Peng3, Qiuwen Tan1, 2, Yanyan Xie1, 2, Haina Zhao3 and Qing Lv1, 220250 citations
- Jin-hu Chen1, Zhen-rong Yang2, Zhi-ming Cai2, Tao Lin2, Ren Lin2, Xin-cheng Su2, Rong-bin Kang2, Lu Lin2, Zai-sheng Ye1 and Yong-jian Zhou220250 citations
- Deogratias M. Katabalo1, 2, Melina Abraham1, Benson R. Kidenya3, Antony Liwa4 and Kristin Schroeder2, 520250 citations
- Xinyi Wang1, Chao Wu2, Siqing Yue3, 4, Mengyuan Zhou1, Enba Zhuo5, Xin Wu1, Yafen Wang1, 6, Bangjie Chen2 and Fan Wang120250 citations
- Guanghui Zhao1, Xu Zhang2, Wei Du2, Junhui Yuan3 and Qigen Fang220250 citations
- Xinyue Gou1, Zhuo Chen2 and Yudi Shangguan320250 citations
- Xiuhua Peng1, Shan Pi2, Hongxing Zhao1, 3, Hupo Bian1, Wenhui Li4, Dongping Deng1, Wenjian Xing5, Haihua Hu6, Shiyu Zhang7, Pengliang Xu4 and …20250 citations
- Jin Wang1, Huan Liu2, Yiman Li3, Xueqin Ma1, Hao Chen1, Xiaoping Luo1, Baolin Zhou1 and Xi Liu120250 citations
- Guanlin Dai1, 2, Furong Tang1, 2, Ping Wang1, 2 and Danqing Wang1, 220250 citations
- Ebtesam HO Nafie, Chiara Pastori and Robert E. Neal II20250 citations
- Jun-Jie Hou, Liang Ding, Yan-Fei Yang and Wei-Wei Li20250 citations
- Multimodal ultrasound radiomic s containing microflow images fo r the prediction of central lymp h node metastasis in papillar y thyroid carcinoma20250 citations
- Jun Li1, Changjun Ma2, Shifeng Tian1, 3, Ailian Liu1, 3, 4, Qingling Song1, 3, Nan Wang1, 3, Qingwei Song1, 3, Liangjie Lin5, Peng Sun5 and Jiazheng …20250 citations
- Salvatore Corallo1, 2, Chiara Milani1, Alessandro Vanoli3, 4, Anna Gallotti5, Anna Pagani2, Francesco Serra2, Marcello Maestri6, Valentina Ravetta7 …20250 citations
- The gut microbiome as a potential predictive biomarker for breast cancer: emerging association and geographic differences20250 citations
- Weijun Li1, Guoyang Sun2, Rui Zhu3, Pindong Li4 and Li Wang120250 citations
- Man Xiao1, 2, Yinghu Yan3, Rui Zhang4, Dan Wang5, Li Wang2, Yameng Zhao6 and Jinhong Yang120250 citations
- Wei Wan1, Huiquan Liu1, Junrong Zou2, Tianpeng Xie3, Guoxi Zhang3, Weihai Ying4 and Xiaofeng Zou1, 2, 320250 citations
- Sijin Chen1, Ruochen Zhang2, Zijun Zou3, Yaojing Yang2, Le Lin2, Liefu Ye2, Jinfeng Wu2, Yuanman Zhang4, Wei Song1, Qichen Wei4 and Yongbao Wei220250 citations
- Ruifang Hu1, Xianping Liu1, Yong Zhang1, Clement Arthur2 and Dongguang Qin320250 citations
- Ruihua Mi1, Shuli Guo2, Weidong Yang3, Lin Wang1, Yixuan Ma1, Lin Chen1, Dongbei Li4, 5 and Xudong Wei120250 citations
- Ruijian You, Yongpeng Ji, Xiao Yang, Qiang Zhao, Yudong Cao, Jinchao Ma, Ziyi Yu, Yushuang Cui, Jinduo Ma, Ruojing Li, Liuyang Miao, Yong Yang, Peng …20250 citations
- Global research landscape of antiangiogenic therapy fo r colorectal cancer: a bibliometri c analysis of mechanistic insight s and clinical advancement s20250 citations
- Ting Hu1, 2, Yisha Liu3, Yu Nie2, Chengpeng Gu2, 4, Guopeng Wang1, 2, Jinze Zhang1, Fang Zhou2, Shangqing Ren2 and Dong Wang220250 citations
- Ting Zhang1, Ruiqing Sun1, Xuejun Lian1, Changyu Wang1, Yuping Li1 and Kang Liu220250 citations
- Yang Wang1, Xiancheng Li2, Hua Yang3, Chaoshan Yin4, Yameng Wu4 and Xiaoke Chen120250 citations
- Prognostic role of fibrinogen-to albumin ratio in patients wit h gynecological cancers: a meta-analysis20250 citations
- Yanhong Du, Anli Zhao, Maoliang Zhang, Zhengping Wang, Liyan Hu and Xiaoyang Qi20250 citations
- Yao Yao1, Wenjuan Di2, Fangkai He2, Bin Liu3, Xue Chen4, Xiaojun Guan5, Zhou Huang6, Ying Wang1 and Depei Wu120250 citations
- Siying Pan1, Chi Lu1, 2, Hongda Lu1, 2 and Hongfeng Zhang320250 citations
- Siyu Xie, Lifeng Ran, Wei Yang, Kun Zhou, Chengbing Jin and Hui Zhu20250 citations
- Feng Wu1, Wenxin Tan2, Panpan Liu2, Weiguang Qiao2 and Tongyin Xing220250 citations
- Hyperprogression disease induced by Sintilimab combined with Oxaliplatin and S-1 after surgery: a case report and20250 citations
- Heng-Jui Chang1, Chiao-Hsu Ke2 and Yu-Shan Wang3, 420240 citations
- Nicola L. Barclay1, Marta Pineda Moncusı1, Annika M. Jödicke1, Daniel Prieto-Alhambra1, 2, Berta Raventos3, Danielle Newby1, Antonella Delmestri1, Wai Yi …20240 citations
- Yuxian Chen1, Yang Li2, Hong Meng1, Chunhai Li1 and Fanlei Kong120240 citations
- Xiaoxiao He1, Sujun Yang2, Jialiang Ren3, Ning Wang4, Min Li1, Yang You1, Yang Li1, Yu Li1, Gaofeng Shi1 and Li Yang120240 citations
- Results: It was found that a 7-feature multivariable model of QUS texture features using a support vector machine (SVM) classifier demonstrated 81% sensitivity …20230 citations
- Comprehensive NGS profiling to enable detection of ALK gene rearrangements and MET amplifications in non-small cell lung cancer20230 citations
- Hongjia Liu1, 2, Dan Zhao2, Yuliang Huang2, 3, Chenguang Li2, Zhengkun Dong1, 2, Hongbo Tian2, Yijie Sun4, Yanye Lu120230 citations
- Jayant Sharad Vaidya1, Uma Jayant Vaidya2, Michael Baum1, Max Kishor Bulsara1, 3, David Joseph4 and Jeffrey S. Tobias5 on behalf of TARGIT-IORT Global …20220 citations
- Martin Uhl1, Stefan Schwab1 and Thomas Efferth 220160 citations
06Reviewer comments
Reviewer comments and rejection reasons for Frontiers in Oncology
No reviewer or editor comments have been shared for this journal yet. Did you submit here? Help other researchers by sharing the comments you received, anonymously.
Share reviewer comments for this journal →Across the reviewer comments researchers have shared with us, the points raised most often are figures, tables and equations (21%), literature and references (12%) and novelty and contribution (10%). Before you submit to Frontiers in Oncology, a Manuscript Audit by a PhD reviewer in your area checks your paper against exactly these points.
Audit my paper before I submit →Not sure yet? Check if your paper is ready for this journal: free, no AI, under 5 secondsPreparing to submit here? Make sure reviewers don't stop at the issues they raise most often. A PhD reviewer in your area can audit your manuscript section by section, and we can convert it into the journal's LaTeX template.
07Similar journals
Journals similar to Frontiers in Oncology
Journals that publish the closest work to the papers above, from the indexing lists:
- Scientific ReportsSCIEScopusJCR 20243 similar papers
- Frontiers in EndocrinologySCIEScopusJCR 20242 similar papers
- Frontiers In PhysiologyJCR 20241 similar paper
- Frontiers in PsychiatrySCIESSCIScopusJCR 20242 similar papers
- Frontiers in PharmacologySCIEScopusJCR 20241 similar paper
- TrialsSCIEScopusJCR 20241 similar paper
08Journal Finder
Find the right journal for your paper
Is Frontiers in Oncology right for your paper? Compare journals
Paste your title, keywords or abstract. We match it against 156,503 published journal papers, by ScholarsColab mentors and other researchers, and show where the closest work appeared, with each journal’s indexing (SCIE, SSCI, AHCI, ESCI, Scopus, JCR 2024).
How it works: no AI or language model is used. Your words are matched against the titles of real published journal papers, by our mentors and by other researchers (shown without names); journals are ranked by how many closely matching papers they published. Indexing comes from the SCIE, SSCI, AHCI, ESCI, Scopus and JCR 2024 lists, matched by journal name; “not found in our indexing lists” does not prove a journal is unindexed. Always check a journal’s scope and current indexing before submitting.
09Questions
Frequently asked questions
What is the impact factor of Frontiers in Oncology?
Based on OpenAlex citation data (October 2026), the 2-year impact factor of Frontiers in Oncology is 2.72: papers it published in the two previous years were cited 2.72 times on average in a year. The journal is listed in JCR 2024, so Clarivate also publishes an official Journal Impact Factor, which can differ.
What is the h-index of Frontiers in Oncology?
The h-index of Frontiers in Oncology is 206 (OpenAlex, October 2026): 206 of its papers have each been cited at least 206 times. Its i10-index is 16,643.
What is the APC of Frontiers in Oncology?
OpenAlex lists an article processing charge (APC) of about US$3,801 for Frontiers in Oncology, an open access journal (data from October 2026). APCs change and can differ by article type, country or discounts, so confirm the current charge on the journal’s website before submitting.
Is Frontiers in Oncology a Q2 journal?
By 2-year citedness, Frontiers in Oncology ranks 142 of 347 journals in Oncology, which places it in Q2 of that Web of Science category. This ranking is calculated by ScholarsColab from OpenAlex data; the official JCR quartile can differ.
Is Frontiers in Oncology indexed in Scopus?
Yes. Frontiers in Oncology appears in the Scopus list, according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Frontiers in Oncology an SCIE journal?
Yes. Frontiers in Oncology is listed in the Science Citation Index Expanded (SCIE), according to the indexing lists used on ScholarsColab (updated 1 March 2026). Always confirm the current status on the official list before submitting.
Is Frontiers in Oncology in Journal Citation Reports (JCR)?
Yes. Frontiers in Oncology is listed in JCR 2024, so it has a Journal Impact Factor. For the current impact factor and quartile, check Journal Citation Reports.
What topics does Frontiers in Oncology publish?
The papers published in Frontiers in Oncology that we track most often mention wang1, zhang1, cancer, chen1, liu1, yang. Check the journal’s aims and scope for its full coverage.
How many papers published in Frontiers in Oncology does ScholarsColab track?
We track 181 papers published in Frontiers in Oncology between 2016 and 2026, cited 0 times in total, with a median of 0 citations per paper.
Does Frontiers in Oncology offer an APC waiver?
Frontiers in Oncology follows the policy of Frontiers: no country list; fee support is granted case by case on demonstrated need. No country rule: the publisher decides case by case, or has no waiver scheme. Rules verified 27 October 2026; confirm on the publisher's page.
Has Frontiers in Oncology retracted papers?
Yes. The Retraction Watch database lists 84 retracted papers in Frontiers in Oncology, 84 of them in the last 10 years; the most common reasons are unreliable results and/or conclusions, concerns/issues about data, concerns/issues about image. A retraction count alone is not a verdict on a journal; look at the trend and the reasons. Data updated October 2026.
Want a PhD expert to choose the journal with you?
Our Journal Selection & Submission service shortlists up to 5 journals that match your manuscript, indexing requirement and target quartile, and handles the submission. If your paper was rejected before, a Manuscript Audit shows what to fix first.
Not sure yet? Check your manuscript for this journal, free · How the process works
Popular journals
- The Lancet
- Nature
- Science
- PLoS ONE
- Scientific Reports
- Journal of the American Chemical Society
- Journal of Applied Physics
- Neurology
- Chemosphere
- Journal of Physical Chemistry
- Astrophysical Journal
- Medicine
- RSC Advances
- Zootaxa
- Chemical Engineering Journal
- International Journal of Biological Macromolecules
- Journal of Molecular Structure
- Physics Letters A
- Journal of Alloys and Compounds
- Journal of Organometallic Chemistry
Browse all journals: indexing, impact factor and reviewer comments →
